Trial Profile
A Phase 1, Open Label, Single-Center, Dose-increasing Study to Determine the Safety and Pharmacokinetics of Single and Repeated oral administration of ivabradine in Healthy Chinese Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Angina pectoris; Chronic heart failure; Coronary artery disease
- Focus Pharmacokinetics
- 11 Apr 2013 New trial record